AGIOS PHARMACEUTICALS, INC. (AGIO) Shareholders’ equity 2016–2025
AGIOS PHARMACEUTICALS, INC. (AGIO) shareholders’ equity at each fiscal year-end, per SEC filings.
$1.2BFY2025 · since FY2016: $358.6M → $1.2B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.2B | -22.6% |
| FY2024 | $1.5B | +90.0% |
| FY2023 | $811.0M | -26.3% |
| FY2022 | $1.1B | -14.8% |
| FY2021 | $1.3B | +223.4% |
| FY2020 | $399.5M | -37.6% |
| FY2019 | $640.5M | -6.8% |
| FY2018 | $687.5M | +83.1% |
| FY2017 | $375.5M | +4.7% |
| FY2016 | $358.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice